Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Breast Neoplasms 2Scleroderma, Localized 1Radiation Injuries 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Pneumonia 1Neurodermatitis 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Multiple Myeloma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lichen Planus 1Leukemia 1Keratoacanthoma 1Keloid 1Hemangioma 1Granuloma Annulare 1Dermoid Cyst 1Dendritic Cell Sarcoma, Interdigitating 1Cicatrix, Hypertrophic 1Cancer Pain 1Bone Neoplasms 1Asthma 1Arthritis, Rheumatoid 1Alopecia Areata 1

Interventions

Saline Solution 1Lidocaine 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Scleroderma, Localized × Adrenal Cortex Hormones × Clear all
NCT03630198 2021-03-11

Pain Outcomes Following Intralesional Corticosteroid Injections

Vanderbilt University Medical Center

Phase 4 Completed
31 enrolled 6 charts

Acne Vulgaris, Alopecia Areata, Dermoid Cyst, Keloid, Keratoacanthoma, Lichen Planus, Neurodermatitis, Scleroderma, Localized, Granuloma Annulare, Cicatrix, Hypertrophic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡